Tenaya Therapeutics
TNYA
68 hedge funds and large institutions have $94.7M invested in Tenaya Therapeutics in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 20 closing their positions.
79% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 14
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
7% less funds holding
Funds holding: 73 → 68 (-5)
7% less capital invested
Capital invested by funds: $102M → $94.7M (-$7.41M)
11.55% less ownership
Funds ownership: 85.19% → 73.64% (-12%)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
84% less call options, than puts
Call options by funds: $12K | Put options by funds: $76K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$10.9M |
| 2 |
CC
Casdin Capital
New York
|
+$6.08M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.76M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$720K |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$582K |
| 3 |
BlackRock
New York
|
-$441K |
| 4 |
Citigroup
New York
|
-$393K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$388K |
TNYA Hedge Fund Activity: Q4 2022 in Review
68 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q4 2022, worth a combined $94.7M — down 7.3% from $102M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of TNYA and 15 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 25 added.
The largest buyer was RA Capital Management, adding an estimated $10.9M. The largest seller was Fidelity Investments, cutting an estimated $720K.
- 68 institutional investors held Tenaya Therapeutics (TNYA) as of Q4 2022, down from 73 in Q3 2022.
- Funds reported $94.7M of Tenaya Therapeutics stock for Q4 2022, down 7.3% quarter-over-quarter.
- 15 funds opened new Tenaya Therapeutics positions in Q4 2022 and 20 closed out, a net change of -5 holders.
- The largest Tenaya Therapeutics buyer in Q4 2022 was RA Capital Management, an estimated $10.9M added.
- The largest Tenaya Therapeutics seller in Q4 2022 was Fidelity Investments, an estimated $720K sold.
Based on aggregated 13F filings for Q4 2022.